Tech vs. cancer The race to make the disease obsolete
One AI system based at Cambridge University used DNA data from The Cancer Genome Atlas to teach itself to identify early ...
Why Summit Therapeutics Rocketed 584% in 2024
Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...